Virabiotics’s MolluscuDerm(TM) Topical Antiviral Therapy Receives The BIO Innovation Award

LAKE JESSAMINE, Fla.--(BUSINESS WIRE)--Virabiotics, Inc, announced today that their new topical antiviral therapy, MolluscuDermTM, received the BIO Innovation Award at the BIO (Biotechnology Industry Organization) 2006 annual meeting. The award is given to the poster that displayed “the most innovative technology, based upon the innovative science behind the technology, the current commercialization potential, and the future market impact of the technology as determined by fellow academics and professionals in the biotechnology arena.